The age of the vaccination of the HPV vaccination of Merida is expanded to the protection effect, safety, and the convenience of appointment is the three elements of the vaccine

Cover reporter Zhou Jiayi

On August 30, Merck (China) Investment Co., Ltd. announced that the new indication certificate of the nine -valent papilloma virus vaccine (winemaking yeast) (hereinafter referred to as "nine -valent HPV vaccine") has been approved by the China National Drug Administration, The approved people who have significantly marked Merck's nine-valent HPV vaccine have also expanded to women 9-45 years old.

It is understood that the nine -valent HPV vaccine uses a three -dose immune program, which is suitable for preventing HPV16, 18, 31, 33, 45, 52, and 58 cervical cancer; HPV6, 11, 16, 18, 31, 33, 45, 52 And the cervical epithelial tumor -like lesions (CIN1/2/3) caused by type 58 and cervical glandular cancer (AIS); and HPV6, 11, 16, 18, 31, 33, 45, 52, and 58 type 58 Continuous infection.

After the nine -valent HPV vaccine is expanded, what are the changes in the attitude of HPV vaccination in the age of the people? The disease prevention information and service platform "about seedlings" are based on 52650 part -sample samples, selected elements from HPV vaccine, changes in the attitude of HPV vaccination before and after the age expansion, and a multi -dimensional survey of health prevention awareness. The analysis of user behavior data published the "Women's HPV Prevention Cognitive Insight Report" (hereinafter referred to as the "Report").

HPV vaccine selection element TOP3: protection effect, safety, and convenient appointment

At present, the HPV vaccine, which has been approved by my country, includes imported Merosa East Four Valentine Vaccine "Jiada Xiu", Nine Valentine Vaccine "Jiada Xiu 9", Grammort's two -valent vaccine "Herrai", and domestic 10,000 Thai creature's binary vaccine "Xin Kening" and the binary vaccine of Watson Biological "Wozawa". The "Report" shows that the protection of vaccines, safety, and convenience of appointment are the primary impact factor for users to choose vaccines. "Import or domestic" and vaccine prices are also factor that users are more concerned about.

After the nine -valent HPV vaccine is expanded, the potential demand for market may surge

After the nine -valent HPV vaccine expands, the people who originally waited for the HPV vaccine at different valence types have also changed. Among the people under the age of 16, 57.8%of the people said they would choose to choose the nine prices first. Among the 16-26 years of age, more than 86%of the respondents said they would continue to choose a nine-valent vaccine. Among the 27-45-year-old waitingrs, 64%of the user plans to make an appointment for nine-valent vaccine after the age of expansion. It can be seen that after the age expansion, the new age groups show preferences for HPV nine -valent vaccines, and potential market demand may further surge.

Nine -price subscriptions have continued to rise, and the supply is not in short.

When the user appoints the nine -valent HPV vaccine and found that the outpatient clinic is short of seedlings, online users generally queue up by subscribing to the seedlings before making an appointment. The data shows that from 2020 to June 2022, the total appointment of about 1.3 million people with a nine -valent HPV vaccine of about the seedling platform was approximately 1.3 million. Compared with the appointment volume, the subscription waiting volume is great and continued to rise. In the first half of 2022, the subscription volume was 18.51 million, which has reached 75%of the annual subscription volume in 2021. The current situation is prominent. With the expansion of the nine-valent vaccine to 9-45 years old, this demand will be further released.

At the same time, nearly 80 % of the users who participated in the survey waiting for the nine -valent HPV vaccine were "over -aged anxiety." In the past, in order to complete the vaccination before the age of 26, more than 70%of users will pay attention to the nine -price seedlings and seedlings to grab seedlings, and make an appointment for multiple platforms online. About 30%of the respondents will also choose to make an appointment for vaccination.

The two -price appointment is "blowout" to increase domestic vaccines. It is expected to quickly increase the HPV vaccine.

Due to the limited supply of nine -valent HPV vaccines and domestic vaccines have been approved to be listed one after another, since 2020, the number of binary HPV vaccines has increased significantly. In 2020 and 2021, from January to June 2022, the domestic second-priced HPV vaccine appointments of the Miao platform were about 98,000, 1.12 million times, and 1.68 million. Among them, the reservation volume in the first half of 2022 reached 1.5 times the total reservation in 2021. With the country's vigorous promotion to increase the coverage of HPV vaccination, domestic binary HPV vaccines quickly supplement the market supply, which has significantly improved.

Vaccination and regular screening are important, and the awareness of prevention is gradually improved

With the popularity of HPV vaccines, Volkswagen's awareness of cervical cancer prevention is gradually increasing. In this survey, more than 85%of the interviewed users who said that they would take their family or friends to take vaccines, and about 67%of people will conduct regular cervical cancer & breast cancer screening, and the HPV vaccine and regular screening are equally important. They are important means to prevent cervical cancer.

- END -